Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Artificial Cells, Nanomedicine, and Biotechnology|June 9, 2016
Lipid-based dispersions of exemestane for improved dissolution rate and intestinal permeability: in vitro and ex vivo characterizationBasanth Babu Eedara, Suresh Bandari
Pharmaceutical Development and Technology|May 14, 2014
Development of ketoprofen loaded proliposomal powders for improved gastric absorption and gastric tolerance: in vitro and in situ evaluationHimabindu Gangishetty, Basanth Babu Eedara, Suresh Bandari
Scientific Reports|December 8, 2019
A STELLA simulation model for in vitro dissolution testing of respirable size particlesBasanth Babu Eedara, Ian G Tucker, Shyamal C Das
Pharmaceutics|December 23, 2022
Dissolution and Absorption of Inhaled Drug Particles in the LungsBasanth Babu Eedara, Rakesh Bastola, Shyamal C Das
International Journal of Pharmaceutics|April 20, 2016
Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosisBasanth Babu Eedara, Ian G Tucker, Shyamal C Das
International Journal of Pharmaceutics|January 27, 2019
In vitro dissolution testing of respirable size anti-tubercular drug particles using a small volume dissolution apparatusBasanth Babu Eedara, Ian G Tucker, Shyamal C Das
Drug Development and Industrial Pharmacy|June 7, 2013
Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studiesBasanth Babu Eedara, Prabhakar Reddy Veerareddy, Raju Jukanti, et al.
Drug Development and Industrial Pharmacy|March 20, 2014
Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluationBindu Ramasahayam, Basanth Babu Eedara, Prabhakar Kandadi, et al.
International Journal of Pharmaceutics|March 11, 2018
The influence of surface active l-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powdersBasanth Babu Eedara, Bhamini Rangnekar, Colin Doyle, et al.
Pharmaceutics|September 28, 2023
Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro CharacterizationBasanth Babu Eedara, Claire Fan, Shubhra Sinha, et al.
Pageof 3